Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Insulin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Insulin Receptor

Chemical Structure Cat. No. Product Name CAS No.
Insulin Chemical Structure
BCP37517 Insulin 12584-58-6
KU14R Chemical Structure
BCP06499 KU14R 189224-48-4
A new I(3)-R antagonist, KU14R (2 (2-ethyl 2,3-dihydro-2-benzofuranyl)-2-imidazole), which selectively blocks the insulin secretory response to imidazolines.
GSK1838705A Chemical Structure
BCP02847 GSK1838705A 1116235-97-2
GSK1838705A is a potent small-molecule IGF-IR, the insulin receptor and anaplastic lymphoma kinase (ALK) inhibitor with IC50 of 2.0, 1.6 and 0.5 nM, respectively.
NVP-AEW541 Chemical Structure
BCP02417 NVP-AEW541 475489-16-8
NVP-AEW541 is an IGF-IR inhibitor with an IC50 of median 3.6 μM.
BMS-754807 Chemical Structure
BCP01926 BMS-754807 1001350-96-4
BMS-754807 is an orally bioavailable antagonist of human insulin-like growth factor type I receptor (IGF-1R) with potential antineoplastic activity.
Linsitinib Chemical Structure
BCP01831 Linsitinib 867160-71-2
Linsitinib is highly potent, orally efficacious and highly selective, dual ATP-competitive tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) (IC50: 35 nM) and insulin receptor (IR) (IC50: 75 nM).
Insulin degludec Chemical Structure
BCP23700 Insulin degludec 844439-96-9
Insulin degludec is an Insulin Analog. The chemical classification of insulin degludec is Insulin.
Human Insulin, Solution Chemical Structure
BCP08894 Human Insulin, Solution 11061-68-0
Insulin(human) is a peptide hormone that regulates the level of sugar (glucose) in the blood and that is produced by the beta cells of the pancreatic islets.
Insulin Chemical Structure
BCP13324 Insulin 11070-73-8
Insulin cattle is a kind of polypeptide hormone that regulates glucose metabolism in pancreatic islet B-cells.
MSDC-0160 Chemical Structure
BCP16099 MSDC-0160 146062-49-9
MSDC-0160 is a prototype mTOT-modulating insulin sensitizer being studied to treat diabetes and Alzheimer's disease.
12下一頁共 12 條記錄 1 / 2 頁 
0086-13720134139
福建36选7奖金 下载温州茶苑麻将 棋牌杀分原理 星悦麻将 网络捕鱼赌博案件 上海十一选五开奖走势 河南22选5玩法 新加坡二分彩开奖号码 有没有可以赌钱的棋牌游戏 上海麻将技巧十句口诀 大众麻将免费下载 海龙王之鱼美人捕鱼游戏机 上海十一选五走势图彩经网 好彩1开奖结果预测 一路发2肖4码默认论坛 325棋牌捕鱼赢了2万 好运南京麻将下载